← Leaderboards
Andrew D Weinberg
Providence Portland Medical Center
$4,972,004
Attributed
$4,972,004
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $586.1K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,972,004 · 3
By mechanism
R01$4,972,004 · 3
Top collaborators
No co-investigators on record.
Most similar at Providence Portland Medical Center
Same institution · by research overlap
- H. G. Archie Bouwer$912,330
- David J. Hinrichs$618,696
- William L Redmond$2,939,722
- Marka Crittenden$2,669,247
- Walter J Urba$2,009,864
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionProteinsMolecularMediatingPropertyPathway InteractionsImmune ResponseIn VivoEquilibriumMalignant NeoplasmsImmunityPeripheralImmune SystemNeoplastic CellCellsAgonistImmunotherapyInterleukin-12Clinical TrialsBaseAntibodiesImmuneCytokineSignal Transduction
Grant awards (18)
To Understand/Augment OX40-mediated Tumor Immunotherapy$287,887
R01 · FY2013 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$306,263
R01 · FY2012 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$306,263
R01 · FY2011 · CA · contact PI
The Importance of T cell Survival in Tumor Immunity$262,259
R01 · FY2011 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$315,735
R01 · FY2010 · CA · contact PI
The Importance of T cell Survival in Tumor Immunity$270,370
R01 · FY2010 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$315,735
R01 · FY2009 · CA · contact PI
The Importance of T cell Survival in Tumor Immunity$270,370
R01 · FY2009 · CA · contact PI
The Importance of T cell Survival in Tumor Immunity$270,370
R01 · FY2008 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$300,210
R01 · FY2007 · CA · contact PI
The Importance of T cell Survival in Tumor Immunity$270,370
R01 · FY2007 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$309,177
R01 · FY2006 · CA · contact PI
To Understand/Augment OX40-mediated Tumor Immunotherapy$316,618
R01 · FY2005 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy$316,618
R01 · FY2004 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy$316,618
R01 · FY2003 · CA
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY$184,364
R01 · FY2002 · CA
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY$178,995
R01 · FY2001 · CA
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY$173,782
R01 · FY2000 · CA